{"protocolSection": {"identificationModule": {"nctId": "NCT00536913", "orgStudyIdInfo": {"id": "D5897C00004"}, "organization": {"fullName": "AstraZeneca", "class": "INDUSTRY"}, "briefTitle": "Evaluation of Safety and Efficacy of Symbicort\u00ae pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma", "officialTitle": "A 4-week, Open-label, Randomized, Multi-centre, Parallel-group Study Evaluating the Safety and Efficacy of 4 Actuations Symbicort\u00ae (Budesonide/Formoterol) HFA pMDI 40/2.25 \u03bcg Twice Daily, With and Without Spacer, in Children (6-11 Years) With Asthma", "acronym": "Spacer"}, "statusModule": {"statusVerifiedDate": "2012-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-09"}, "primaryCompletionDateStruct": {"date": "2008-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-09-26", "studyFirstSubmitQcDate": "2007-09-27", "studyFirstPostDateStruct": {"date": "2007-09-28", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-02-16", "resultsFirstSubmitQcDate": "2012-01-23", "resultsFirstPostDateStruct": {"date": "2012-02-27", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2012-04-05", "lastUpdatePostDateStruct": {"date": "2012-04-06", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "AstraZeneca", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of the study is to compare Symbicort pMDI with and without spacer in terms of steroid potency, improvement of lung function and asthma symptoms in children with asthma (6-11 years)."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Symbicort pMDI", "spacer", "children"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 107, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "With Spacer", "type": "EXPERIMENTAL", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer", "interventionNames": ["Drug: Budesonide/formoterol pMDI 40/2.25ug + spacer"]}, {"label": "Without Spacer", "type": "EXPERIMENTAL", "description": "Budesonide/formoterol pMDI 40/2.25 ug", "interventionNames": ["Drug: Budesonide/formoterol pMDI 40/2.25 ug"]}], "interventions": [{"type": "DRUG", "name": "Budesonide/formoterol pMDI 40/2.25ug + spacer", "armGroupLabels": ["With Spacer"]}, {"type": "DRUG", "name": "Budesonide/formoterol pMDI 40/2.25 ug", "armGroupLabels": ["Without Spacer"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Urinary Free Cortisol (UFC)", "description": "Ratio between the value at the end of treatment and the value at start of treatment, including only patients with values at both baseline and end of treatment", "timeFrame": "At baseline and 4 weeks"}], "secondaryOutcomes": [{"measure": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "Changes in FEV1 from baseline to the mean value at 2 weeks to 4 weeks with the baseline value as a covariate.", "timeFrame": "At baseline, at 2 weeks and 4 weeks"}, {"measure": "Morning Peak Expiratory Flow (mPEF)", "description": "Change in average value from the run-in to the treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry were estimated using linear interpolation.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}, {"measure": "Evening Peak Expiratory Flow (ePEF)", "description": "Change in average value from the run-in to the treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation. Missing data between the first and last entry were estimated using linear interpolation.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}, {"measure": "Asthma Symptoms at Night", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}, {"measure": "Asthma Symptoms at Day", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}, {"measure": "Percentage of Nights With Awakenings Due to Asthma", "description": "Change in Percentage of nights with awakenings, average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}, {"measure": "Use of Rescue Medication at Night", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}, {"measure": "Use of Rescue Medication at Day", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation.", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* children 6-11 years, diagnosed asthma treated\n* 6 months, PEF\n* 50% of predicted normal value pre-bronchodilator\n\nExclusion Criteria:\n\n* current systemic glucocorticosteroids usage\n* current respiratory infection\n* any significant disease or disorder as judged by investigator", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Years", "maximumAge": "11 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Tomas Anderson, MD PhD", "affiliation": "AstraZeneca", "role": "STUDY_DIRECTOR"}, {"name": "Piotr Kuna, MD PhD", "affiliation": "Uniwersytecki Spital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Research Site", "city": "Budapest", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Research Site", "city": "Debrecen", "country": "Hungary", "geoPoint": {"lat": 47.53333, "lon": 21.63333}}, {"facility": "Research Site", "city": "Kaposvar", "country": "Hungary", "geoPoint": {"lat": 46.36667, "lon": 17.8}}, {"facility": "Research Site", "city": "Bialystok", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Research Site", "city": "Bydgoszcz", "country": "Poland", "geoPoint": {"lat": 53.1235, "lon": 18.00762}}, {"facility": "Research Site", "city": "Bytom", "country": "Poland", "geoPoint": {"lat": 50.34802, "lon": 18.93282}}, {"facility": "Research Site", "city": "Karpacz", "country": "Poland", "geoPoint": {"lat": 50.77669, "lon": 15.75594}}, {"facility": "Research Site", "city": "Krakow", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Research Site", "city": "Lodz", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Research Site", "city": "Warszawa", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Research Site", "city": "Moscow", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "137 subjects enrolled; 30 non randomised: 26 failed inclusion criteria, 2 voluntary discontinuations, 1 incorrect enrolment, 1 adverse event. 107 subjects were randomised", "groups": [{"id": "FG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "FG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "55"}, {"groupId": "FG001", "numSubjects": "52"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "55"}, {"groupId": "FG001", "numSubjects": "52"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "BG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "55"}, {"groupId": "BG001", "value": "52"}, {"groupId": "BG002", "value": "107"}]}], "measures": [{"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "8.6", "lowerLimit": "6", "upperLimit": "11"}, {"groupId": "BG001", "value": "8.9", "lowerLimit": "6", "upperLimit": "11"}, {"groupId": "BG002", "value": "8.7", "lowerLimit": "6", "upperLimit": "11"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "22"}, {"groupId": "BG002", "value": "43"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "34"}, {"groupId": "BG001", "value": "30"}, {"groupId": "BG002", "value": "64"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Urinary Free Cortisol (UFC)", "description": "Ratio between the value at the end of treatment and the value at start of treatment, including only patients with values at both baseline and end of treatment", "reportingStatus": "POSTED", "paramType": "GEOMETRIC_MEAN", "dispersionType": "Full Range", "unitOfMeasure": "Ratio", "timeFrame": "At baseline and 4 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "54"}, {"groupId": "OG001", "value": "51"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.86", "lowerLimit": "0.20", "upperLimit": "2.4"}, {"groupId": "OG001", "value": "1.03", "lowerLimit": "0.12", "upperLimit": "5.4"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "Changes in FEV1 from baseline to the mean value at 2 weeks to 4 weeks with the baseline value as a covariate.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Full Range", "unitOfMeasure": "Liters", "timeFrame": "At baseline, at 2 weeks and 4 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.17", "spread": "-0.38", "lowerLimit": "-0.38", "upperLimit": "0.76"}, {"groupId": "OG001", "value": "0.14", "spread": "-0.34", "lowerLimit": "-0.34", "upperLimit": "0.82"}]}]}]}, {"type": "SECONDARY", "title": "Morning Peak Expiratory Flow (mPEF)", "description": "Change in average value from the run-in to the treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry were estimated using linear interpolation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/min", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.70", "spread": "24.6"}, {"groupId": "OG001", "value": "19.50", "spread": "25.1"}]}]}]}, {"type": "SECONDARY", "title": "Evening Peak Expiratory Flow (ePEF)", "description": "Change in average value from the run-in to the treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation. Missing data between the first and last entry were estimated using linear interpolation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/min", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27.00", "spread": "27.7"}, {"groupId": "OG001", "value": "15.30", "spread": "23.0"}]}]}]}, {"type": "SECONDARY", "title": "Asthma Symptoms at Night", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Units on a scale", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.20", "spread": "0.46"}, {"groupId": "OG001", "value": "-0.21", "spread": "0.39"}]}]}]}, {"type": "SECONDARY", "title": "Asthma Symptoms at Day", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Units on a scale", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.25", "spread": "0.43"}, {"groupId": "OG001", "value": "-0.28", "spread": "0.41"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Nights With Awakenings Due to Asthma", "description": "Change in Percentage of nights with awakenings, average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percentage of nights", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-13.80", "spread": "27.2"}, {"groupId": "OG001", "value": "-8.20", "spread": "23.8"}]}]}]}, {"type": "SECONDARY", "title": "Use of Rescue Medication at Night", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Inhalations", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.21", "spread": "0.50"}, {"groupId": "OG001", "value": "-0.14", "spread": "0.38"}]}]}]}, {"type": "SECONDARY", "title": "Use of Rescue Medication at Day", "description": "Change in average value from the run-in to treatment period, calculated using all available data for the 10 last days of run-in, and all available data after randomisation.Missing data between the first and last entry estimated using linear interpolation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Inhalations", "timeFrame": "Daily during run-in and daily during treatment period of 6 weeks", "groups": [{"id": "OG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer"}, {"id": "OG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "52"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.30", "spread": "0.56"}, {"groupId": "OG001", "value": "-0.19", "spread": "0.41"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "eventGroups": [{"id": "EG000", "title": "With Spacer", "description": "Budesonide/formoterol pMDI 40/2.25ug + spacer", "seriousNumAffected": 0, "seriousNumAtRisk": 55, "otherNumAffected": 0, "otherNumAtRisk": 55}, {"id": "EG001", "title": "Without Spacer", "description": "Budesonide/formoterol pMDI 40/2.25 ug", "seriousNumAffected": 0, "seriousNumAtRisk": 52, "otherNumAffected": 0, "otherNumAtRisk": 52}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true}, "pointOfContact": {"title": "Gerard Lynch", "organization": "AstraZeneca", "email": "aztrial_results_posting@astrazeneca.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000019819", "term": "Budesonide"}, {"id": "D000068759", "term": "Formoterol Fumarate"}, {"id": "D000069502", "term": "Budesonide, Formoterol Fumarate Drug Combination"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M21711", "name": "Budesonide", "asFound": "Of 1", "relevance": "HIGH"}, {"id": "M304", "name": "Formoterol Fumarate", "asFound": "Nicotine", "relevance": "HIGH"}, {"id": "M452", "name": "Budesonide, Formoterol Fumarate Drug Combination", "asFound": "Trigger point", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}